News Conference News ACC 2012 RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years March 26, 2012
News Conference News ACC 2012 CPORT-E: PCI Outcomes Similar Regardless of On-Site Cardiac Surgery March 25, 2012
News Conference News ACC 2012 Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES Jason Kahn March 24, 2012
News Conference News ACC 2012 Anti-inflammatory Lowers In-Stent Late Loss After BMS Implantation March 24, 2012
News Conference News ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions Yael L. Maxwell November 30, 2011
News Conference News COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions Jason Kahn November 30, 2011
News Conference News TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year L.A. McKeown November 28, 2011
News Conference News PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis November 27, 2011
News Conference News RIBS III: Alternative DES Best Bet for DES In-Stent Restenosis November 22, 2011
News Conference News Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version November 20, 2011
News Conference News Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk November 17, 2011
News Conference News ‘Judicious Use’ of DES in Low-Risk Patients Could Save Over $200 Million per Year November 16, 2011
News Conference News PRISM Individualized Informed Consent Improves PCI Choice, Experience November 14, 2011
News Conference News Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS September 02, 2011
News Conference News Landmark Analyses Show Downside of Prolonged Antiplatelet Therapy September 02, 2011
News Conference News RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority August 31, 2011
News Conference News EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out May 23, 2011